nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezetimibe—Transaminases increased—Carmustine—malignant glioma	0.0114	0.0288	CcSEcCtD
Ezetimibe—Interstitial lung disease—Carmustine—malignant glioma	0.00984	0.0248	CcSEcCtD
Ezetimibe—Myopathy—Temozolomide—malignant glioma	0.0096	0.0242	CcSEcCtD
Ezetimibe—Interstitial lung disease—Temozolomide—malignant glioma	0.00951	0.0239	CcSEcCtD
Ezetimibe—Memory impairment—Temozolomide—malignant glioma	0.00858	0.0216	CcSEcCtD
Ezetimibe—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.00818	0.0206	CcSEcCtD
Ezetimibe—Drug interaction—Carmustine—malignant glioma	0.00751	0.0189	CcSEcCtD
Ezetimibe—Viral infection—Temozolomide—malignant glioma	0.00745	0.0188	CcSEcCtD
Ezetimibe—Neck pain—Carmustine—malignant glioma	0.00705	0.0177	CcSEcCtD
Ezetimibe—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00673	0.0169	CcSEcCtD
Ezetimibe—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00562	0.0141	CcSEcCtD
Ezetimibe—Hepatic failure—Temozolomide—malignant glioma	0.00544	0.0137	CcSEcCtD
Ezetimibe—Amnesia—Carmustine—malignant glioma	0.00538	0.0135	CcSEcCtD
Ezetimibe—Hot flush—Temozolomide—malignant glioma	0.00522	0.0131	CcSEcCtD
Ezetimibe—Amnesia—Temozolomide—malignant glioma	0.0052	0.0131	CcSEcCtD
Ezetimibe—Menopausal symptoms—Temozolomide—malignant glioma	0.00518	0.013	CcSEcCtD
Ezetimibe—Liver function test abnormal—Carmustine—malignant glioma	0.00467	0.0117	CcSEcCtD
Ezetimibe—Muscular weakness—Carmustine—malignant glioma	0.00446	0.0112	CcSEcCtD
Ezetimibe—Breast disorder—Temozolomide—malignant glioma	0.00442	0.0111	CcSEcCtD
Ezetimibe—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.0044	0.0111	CcSEcCtD
Ezetimibe—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00431	0.0108	CcSEcCtD
Ezetimibe—Muscular weakness—Temozolomide—malignant glioma	0.00431	0.0108	CcSEcCtD
Ezetimibe—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00392	0.00988	CcSEcCtD
Ezetimibe—Erectile dysfunction—Temozolomide—malignant glioma	0.00389	0.00979	CcSEcCtD
Ezetimibe—Photosensitivity reaction—Temozolomide—malignant glioma	0.00385	0.0097	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Carmustine—malignant glioma	0.00382	0.00961	CcSEcCtD
Ezetimibe—Infestation NOS—Temozolomide—malignant glioma	0.00377	0.00948	CcSEcCtD
Ezetimibe—Infestation—Temozolomide—malignant glioma	0.00377	0.00948	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Temozolomide—malignant glioma	0.00369	0.00929	CcSEcCtD
Ezetimibe—Hepatobiliary disease—Temozolomide—malignant glioma	0.00356	0.00896	CcSEcCtD
Ezetimibe—Sinusitis—Temozolomide—malignant glioma	0.00353	0.00889	CcSEcCtD
Ezetimibe—Oedema peripheral—Carmustine—malignant glioma	0.00345	0.00867	CcSEcCtD
Ezetimibe—Connective tissue disorder—Carmustine—malignant glioma	0.00344	0.00865	CcSEcCtD
Ezetimibe—Hepatitis—Temozolomide—malignant glioma	0.00338	0.00851	CcSEcCtD
Ezetimibe—Pharyngitis—Temozolomide—malignant glioma	0.00335	0.00844	CcSEcCtD
Ezetimibe—Flunarizine—CYP2B6—malignant glioma	0.00335	1	CrCbGaD
Ezetimibe—Oedema peripheral—Temozolomide—malignant glioma	0.00333	0.00838	CcSEcCtD
Ezetimibe—Connective tissue disorder—Temozolomide—malignant glioma	0.00332	0.00836	CcSEcCtD
Ezetimibe—Flushing—Carmustine—malignant glioma	0.00325	0.00817	CcSEcCtD
Ezetimibe—Erythema multiforme—Temozolomide—malignant glioma	0.0032	0.00804	CcSEcCtD
Ezetimibe—Flushing—Temozolomide—malignant glioma	0.00314	0.0079	CcSEcCtD
Ezetimibe—Alopecia—Carmustine—malignant glioma	0.00309	0.00778	CcSEcCtD
Ezetimibe—Angiopathy—Temozolomide—malignant glioma	0.00307	0.00772	CcSEcCtD
Ezetimibe—Mental disorder—Carmustine—malignant glioma	0.00306	0.00771	CcSEcCtD
Ezetimibe—Immune system disorder—Temozolomide—malignant glioma	0.00305	0.00768	CcSEcCtD
Ezetimibe—Mediastinal disorder—Temozolomide—malignant glioma	0.00305	0.00767	CcSEcCtD
Ezetimibe—Erythema—Carmustine—malignant glioma	0.00304	0.00766	CcSEcCtD
Ezetimibe—Malnutrition—Carmustine—malignant glioma	0.00304	0.00766	CcSEcCtD
Ezetimibe—Alopecia—Temozolomide—malignant glioma	0.00299	0.00752	CcSEcCtD
Ezetimibe—Mental disorder—Temozolomide—malignant glioma	0.00296	0.00745	CcSEcCtD
Ezetimibe—Back pain—Carmustine—malignant glioma	0.00295	0.00741	CcSEcCtD
Ezetimibe—Malnutrition—Temozolomide—malignant glioma	0.00294	0.00741	CcSEcCtD
Ezetimibe—Erythema—Temozolomide—malignant glioma	0.00294	0.00741	CcSEcCtD
Ezetimibe—Back pain—Temozolomide—malignant glioma	0.00285	0.00716	CcSEcCtD
Ezetimibe—Anaemia—Carmustine—malignant glioma	0.00281	0.00708	CcSEcCtD
Ezetimibe—Ill-defined disorder—Temozolomide—malignant glioma	0.00273	0.00687	CcSEcCtD
Ezetimibe—Anaemia—Temozolomide—malignant glioma	0.00272	0.00685	CcSEcCtD
Ezetimibe—Angioedema—Temozolomide—malignant glioma	0.00269	0.00677	CcSEcCtD
Ezetimibe—Malaise—Temozolomide—malignant glioma	0.00265	0.00668	CcSEcCtD
Ezetimibe—Hypertension—Carmustine—malignant glioma	0.00263	0.00662	CcSEcCtD
Ezetimibe—Palpitations—Temozolomide—malignant glioma	0.0026	0.00655	CcSEcCtD
Ezetimibe—Chest pain—Carmustine—malignant glioma	0.00259	0.00652	CcSEcCtD
Ezetimibe—Myalgia—Carmustine—malignant glioma	0.00259	0.00652	CcSEcCtD
Ezetimibe—Cough—Temozolomide—malignant glioma	0.00257	0.00646	CcSEcCtD
Ezetimibe—Hypertension—Temozolomide—malignant glioma	0.00254	0.00639	CcSEcCtD
Ezetimibe—Confusional state—Carmustine—malignant glioma	0.00251	0.00631	CcSEcCtD
Ezetimibe—Arthralgia—Temozolomide—malignant glioma	0.00251	0.00631	CcSEcCtD
Ezetimibe—Myalgia—Temozolomide—malignant glioma	0.00251	0.00631	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00249	0.00626	CcSEcCtD
Ezetimibe—Discomfort—Temozolomide—malignant glioma	0.00248	0.00623	CcSEcCtD
Ezetimibe—Infection—Carmustine—malignant glioma	0.00247	0.00621	CcSEcCtD
Ezetimibe—Dry mouth—Temozolomide—malignant glioma	0.00245	0.00617	CcSEcCtD
Ezetimibe—Thrombocytopenia—Carmustine—malignant glioma	0.00243	0.00612	CcSEcCtD
Ezetimibe—Confusional state—Temozolomide—malignant glioma	0.00242	0.00609	CcSEcCtD
Ezetimibe—Anaphylactic shock—Temozolomide—malignant glioma	0.0024	0.00604	CcSEcCtD
Ezetimibe—Infection—Temozolomide—malignant glioma	0.00239	0.00601	CcSEcCtD
Ezetimibe—Nervous system disorder—Temozolomide—malignant glioma	0.00236	0.00593	CcSEcCtD
Ezetimibe—Thrombocytopenia—Temozolomide—malignant glioma	0.00235	0.00592	CcSEcCtD
Ezetimibe—Skin disorder—Temozolomide—malignant glioma	0.00233	0.00587	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00226	0.0057	CcSEcCtD
Ezetimibe—Insomnia—Carmustine—malignant glioma	0.00225	0.00566	CcSEcCtD
Ezetimibe—Paraesthesia—Carmustine—malignant glioma	0.00223	0.00562	CcSEcCtD
Ezetimibe—Dyspnoea—Carmustine—malignant glioma	0.00222	0.00558	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00219	0.00551	CcSEcCtD
Ezetimibe—Insomnia—Temozolomide—malignant glioma	0.00217	0.00547	CcSEcCtD
Ezetimibe—Decreased appetite—Carmustine—malignant glioma	0.00216	0.00544	CcSEcCtD
Ezetimibe—Paraesthesia—Temozolomide—malignant glioma	0.00216	0.00543	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Carmustine—malignant glioma	0.00215	0.0054	CcSEcCtD
Ezetimibe—Dyspnoea—Temozolomide—malignant glioma	0.00214	0.00539	CcSEcCtD
Ezetimibe—Constipation—Carmustine—malignant glioma	0.00213	0.00535	CcSEcCtD
Ezetimibe—Pain—Carmustine—malignant glioma	0.00213	0.00535	CcSEcCtD
Ezetimibe—Dyspepsia—Temozolomide—malignant glioma	0.00211	0.00532	CcSEcCtD
Ezetimibe—Decreased appetite—Temozolomide—malignant glioma	0.00209	0.00525	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00207	0.00522	CcSEcCtD
Ezetimibe—Fatigue—Temozolomide—malignant glioma	0.00207	0.00521	CcSEcCtD
Ezetimibe—Constipation—Temozolomide—malignant glioma	0.00205	0.00517	CcSEcCtD
Ezetimibe—Pain—Temozolomide—malignant glioma	0.00205	0.00517	CcSEcCtD
Ezetimibe—Feeling abnormal—Carmustine—malignant glioma	0.00205	0.00515	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Carmustine—malignant glioma	0.00203	0.00511	CcSEcCtD
Ezetimibe—Feeling abnormal—Temozolomide—malignant glioma	0.00198	0.00498	CcSEcCtD
Ezetimibe—Abdominal pain—Carmustine—malignant glioma	0.00196	0.00494	CcSEcCtD
Ezetimibe—Body temperature increased—Carmustine—malignant glioma	0.00196	0.00494	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Temozolomide—malignant glioma	0.00196	0.00494	CcSEcCtD
Ezetimibe—Urticaria—Temozolomide—malignant glioma	0.00191	0.0048	CcSEcCtD
Ezetimibe—Abdominal pain—Temozolomide—malignant glioma	0.0019	0.00478	CcSEcCtD
Ezetimibe—Body temperature increased—Temozolomide—malignant glioma	0.0019	0.00478	CcSEcCtD
Ezetimibe—Hypersensitivity—Carmustine—malignant glioma	0.00183	0.00461	CcSEcCtD
Ezetimibe—Asthenia—Carmustine—malignant glioma	0.00178	0.00449	CcSEcCtD
Ezetimibe—Hypersensitivity—Temozolomide—malignant glioma	0.00177	0.00445	CcSEcCtD
Ezetimibe—Asthenia—Temozolomide—malignant glioma	0.00172	0.00434	CcSEcCtD
Ezetimibe—Diarrhoea—Carmustine—malignant glioma	0.0017	0.00428	CcSEcCtD
Ezetimibe—Pruritus—Temozolomide—malignant glioma	0.0017	0.00428	CcSEcCtD
Ezetimibe—Dizziness—Carmustine—malignant glioma	0.00164	0.00414	CcSEcCtD
Ezetimibe—Diarrhoea—Temozolomide—malignant glioma	0.00164	0.00414	CcSEcCtD
Ezetimibe—Dizziness—Temozolomide—malignant glioma	0.00159	0.004	CcSEcCtD
Ezetimibe—Vomiting—Carmustine—malignant glioma	0.00158	0.00398	CcSEcCtD
Ezetimibe—Rash—Carmustine—malignant glioma	0.00157	0.00394	CcSEcCtD
Ezetimibe—Dermatitis—Carmustine—malignant glioma	0.00157	0.00394	CcSEcCtD
Ezetimibe—Headache—Carmustine—malignant glioma	0.00156	0.00392	CcSEcCtD
Ezetimibe—Vomiting—Temozolomide—malignant glioma	0.00153	0.00384	CcSEcCtD
Ezetimibe—Rash—Temozolomide—malignant glioma	0.00151	0.00381	CcSEcCtD
Ezetimibe—Dermatitis—Temozolomide—malignant glioma	0.00151	0.00381	CcSEcCtD
Ezetimibe—Headache—Temozolomide—malignant glioma	0.0015	0.00379	CcSEcCtD
Ezetimibe—Nausea—Carmustine—malignant glioma	0.00148	0.00372	CcSEcCtD
Ezetimibe—Nausea—Temozolomide—malignant glioma	0.00143	0.00359	CcSEcCtD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.0002	0.000334	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000198	0.000331	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—PIK3CB—malignant glioma	0.000197	0.000329	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.000197	0.000329	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IL1B—malignant glioma	0.000197	0.000328	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—CASP3—malignant glioma	0.000196	0.000328	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IL2—malignant glioma	0.000196	0.000327	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—PTGS2—malignant glioma	0.000195	0.000326	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.000195	0.000326	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000195	0.000325	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	0.000192	0.000321	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—IDH1—malignant glioma	0.000189	0.000316	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—IDH1—malignant glioma	0.000189	0.000316	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000189	0.000315	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—BCAN—malignant glioma	0.000188	0.000314	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000184	0.000306	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—SPHK1—malignant glioma	0.000183	0.000305	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—SPHK1—malignant glioma	0.000183	0.000305	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000182	0.000304	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CYP2C18—malignant glioma	0.000179	0.000299	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CYP2C18—malignant glioma	0.000179	0.000299	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—IDH2—malignant glioma	0.000179	0.000298	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.000177	0.000296	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—PTEN—malignant glioma	0.000177	0.000295	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000175	0.000292	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GSTT1—malignant glioma	0.000171	0.000285	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—PTEN—malignant glioma	0.00017	0.000284	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000169	0.000282	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CYP2B6—malignant glioma	0.000168	0.00028	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—VEGFA—malignant glioma	0.000167	0.000278	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—CAV1—malignant glioma	0.000165	0.000276	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—PIK3CA—malignant glioma	0.000165	0.000275	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—IDH2—malignant glioma	0.000164	0.000273	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PTGS1—malignant glioma	0.00016	0.000267	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.000158	0.000264	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000154	0.000258	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000154	0.000257	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CYP2B6—malignant glioma	0.000154	0.000257	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—IDH1—malignant glioma	0.000154	0.000256	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—IDH2—malignant glioma	0.000152	0.000253	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PIK3CG—malignant glioma	0.000151	0.000251	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—SPHK1—malignant glioma	0.000149	0.000248	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000149	0.000248	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—BCHE—malignant glioma	0.000149	0.000248	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—SLC5A5—malignant glioma	0.000147	0.000245	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CYP2C18—malignant glioma	0.000146	0.000243	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PPARG—malignant glioma	0.000145	0.000242	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GSTT1—malignant glioma	0.000145	0.000242	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GSTT1—malignant glioma	0.000145	0.000242	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—TNF—malignant glioma	0.000143	0.000238	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CYP2B6—malignant glioma	0.000143	0.000238	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.000142	0.000237	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—IDH1—malignant glioma	0.000141	0.000235	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.000137	0.000229	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000136	0.000228	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—SPHK1—malignant glioma	0.000136	0.000227	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.000136	0.000227	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PTGS1—malignant glioma	0.000136	0.000227	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PTGS1—malignant glioma	0.000136	0.000227	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000135	0.000226	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000135	0.000225	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—AKT1—malignant glioma	0.000135	0.000225	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CYP2C18—malignant glioma	0.000133	0.000223	CbGpPWpGaD
Ezetimibe—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000133	0.000222	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PIK3CD—malignant glioma	0.000132	0.000221	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—IDH1—malignant glioma	0.00013	0.000218	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—COX8A—malignant glioma	0.000127	0.000212	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—BCHE—malignant glioma	0.000126	0.000211	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—BCHE—malignant glioma	0.000126	0.000211	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—SPHK1—malignant glioma	0.000126	0.000211	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000126	0.00021	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—PIK3CA—malignant glioma	0.000125	0.000208	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—SLC5A5—malignant glioma	0.000125	0.000208	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—SLC5A5—malignant glioma	0.000125	0.000208	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CYP2C18—malignant glioma	0.000124	0.000206	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	0.000123	0.000205	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—PIK3CA—malignant glioma	0.00012	0.000201	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GSTP1—malignant glioma	0.000118	0.000197	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000118	0.000197	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GSTT1—malignant glioma	0.000118	0.000197	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000117	0.000195	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.000116	0.000193	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PIK3CB—malignant glioma	0.000115	0.000192	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CAT—malignant glioma	0.000115	0.000192	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000115	0.000192	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000115	0.000191	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PTGS2—malignant glioma	0.000114	0.000191	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000111	0.000185	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PTGS1—malignant glioma	0.00011	0.000184	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.00011	0.000183	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—NCOR1—malignant glioma	0.000109	0.000181	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000108	0.000181	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ASMT—malignant glioma	0.000108	0.00018	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000108	0.00018	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GSTT1—malignant glioma	0.000108	0.00018	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000108	0.00018	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.000107	0.000178	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000104	0.000174	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—BCHE—malignant glioma	0.000103	0.000171	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—AKT1—malignant glioma	0.000102	0.00017	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000102	0.00017	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—BCAN—malignant glioma	0.000102	0.00017	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—SLC5A5—malignant glioma	0.000101	0.000169	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PTGS1—malignant glioma	0.000101	0.000169	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000101	0.000168	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GSTP1—malignant glioma	0.000101	0.000168	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GSTP1—malignant glioma	0.000101	0.000168	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GSTT1—malignant glioma	0.0001	0.000167	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PTEN—malignant glioma	9.97e-05	0.000166	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	9.93e-05	0.000166	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—AKT1—malignant glioma	9.82e-05	0.000164	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CAT—malignant glioma	9.78e-05	0.000163	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CAT—malignant glioma	9.78e-05	0.000163	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	9.69e-05	0.000162	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	9.45e-05	0.000158	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—BCHE—malignant glioma	9.41e-05	0.000157	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PTGS1—malignant glioma	9.37e-05	0.000156	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—SLC5A5—malignant glioma	9.29e-05	0.000155	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—NCOR1—malignant glioma	9.24e-05	0.000154	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—NCOR1—malignant glioma	9.24e-05	0.000154	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—RAF1—malignant glioma	9.11e-05	0.000152	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	9.1e-05	0.000152	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CAV1—malignant glioma	8.85e-05	0.000148	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.79e-05	0.000147	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—BCHE—malignant glioma	8.71e-05	0.000145	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.71e-05	0.000145	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—SLC5A5—malignant glioma	8.6e-05	0.000144	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—RAF1—malignant glioma	8.56e-05	0.000143	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	8.22e-05	0.000137	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—IDH2—malignant glioma	8.2e-05	0.000137	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GSTP1—malignant glioma	8.17e-05	0.000136	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PIK3CG—malignant glioma	8.07e-05	0.000135	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CAT—malignant glioma	7.95e-05	0.000133	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—RAF1—malignant glioma	7.92e-05	0.000132	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—COX8A—malignant glioma	7.84e-05	0.000131	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PPARG—malignant glioma	7.78e-05	0.00013	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP2B6—malignant glioma	7.71e-05	0.000129	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.59e-05	0.000127	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	7.56e-05	0.000126	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CAV1—malignant glioma	7.53e-05	0.000126	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CAV1—malignant glioma	7.53e-05	0.000126	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—NCOR1—malignant glioma	7.5e-05	0.000125	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GSTP1—malignant glioma	7.48e-05	0.000125	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	7.4e-05	0.000123	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CAT—malignant glioma	7.28e-05	0.000121	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.19e-05	0.00012	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PIK3CD—malignant glioma	7.09e-05	0.000118	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—IDH1—malignant glioma	7.05e-05	0.000118	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	7.05e-05	0.000118	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PIK3CA—malignant glioma	7.03e-05	0.000117	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	6.99e-05	0.000117	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GSTP1—malignant glioma	6.93e-05	0.000116	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—NCOR1—malignant glioma	6.88e-05	0.000115	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PIK3CG—malignant glioma	6.86e-05	0.000114	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PIK3CG—malignant glioma	6.86e-05	0.000114	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SPHK1—malignant glioma	6.82e-05	0.000114	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CAT—malignant glioma	6.74e-05	0.000112	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP2C18—malignant glioma	6.68e-05	0.000111	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ASMT—malignant glioma	6.66e-05	0.000111	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PPARG—malignant glioma	6.62e-05	0.00011	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PPARG—malignant glioma	6.62e-05	0.00011	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	6.42e-05	0.000107	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—NCOR1—malignant glioma	6.37e-05	0.000106	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—BCAN—malignant glioma	6.27e-05	0.000105	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	6.21e-05	0.000104	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PIK3CB—malignant glioma	6.18e-05	0.000103	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PTGS2—malignant glioma	6.12e-05	0.000102	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CAV1—malignant glioma	6.12e-05	0.000102	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PIK3CD—malignant glioma	6.03e-05	0.000101	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PIK3CD—malignant glioma	6.03e-05	0.000101	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—AKT1—malignant glioma	5.75e-05	9.59e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CAV1—malignant glioma	5.61e-05	9.35e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PIK3CG—malignant glioma	5.57e-05	9.3e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTT1—malignant glioma	5.4e-05	9.02e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PPARG—malignant glioma	5.38e-05	8.97e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.36e-05	8.94e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PTEN—malignant glioma	5.34e-05	8.91e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PIK3CB—malignant glioma	5.25e-05	8.77e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PIK3CB—malignant glioma	5.25e-05	8.77e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	5.25e-05	8.75e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PTGS2—malignant glioma	5.21e-05	8.69e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PTGS2—malignant glioma	5.21e-05	8.69e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CAV1—malignant glioma	5.19e-05	8.66e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PIK3CG—malignant glioma	5.11e-05	8.52e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PTGS1—malignant glioma	5.06e-05	8.45e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—IDH2—malignant glioma	5.05e-05	8.43e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PPARG—malignant glioma	4.93e-05	8.22e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PIK3CD—malignant glioma	4.9e-05	8.17e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP2B6—malignant glioma	4.75e-05	7.92e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PIK3CG—malignant glioma	4.73e-05	7.89e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—BCHE—malignant glioma	4.71e-05	7.86e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SLC5A5—malignant glioma	4.65e-05	7.76e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PPARG—malignant glioma	4.56e-05	7.61e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PTEN—malignant glioma	4.54e-05	7.58e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PTEN—malignant glioma	4.54e-05	7.58e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PIK3CD—malignant glioma	4.49e-05	7.49e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—IDH1—malignant glioma	4.34e-05	7.25e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	4.28e-05	7.15e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PIK3CB—malignant glioma	4.27e-05	7.12e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PTGS2—malignant glioma	4.23e-05	7.06e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SPHK1—malignant glioma	4.2e-05	7.01e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PIK3CD—malignant glioma	4.16e-05	6.93e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP2C18—malignant glioma	4.12e-05	6.87e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PIK3CB—malignant glioma	3.91e-05	6.53e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PTGS2—malignant glioma	3.88e-05	6.47e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PIK3CA—malignant glioma	3.77e-05	6.29e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTP1—malignant glioma	3.75e-05	6.25e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PTEN—malignant glioma	3.69e-05	6.16e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CAT—malignant glioma	3.65e-05	6.08e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PIK3CB—malignant glioma	3.62e-05	6.04e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PTGS2—malignant glioma	3.59e-05	5.99e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NCOR1—malignant glioma	3.44e-05	5.74e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PTEN—malignant glioma	3.38e-05	5.64e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTT1—malignant glioma	3.33e-05	5.56e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PIK3CA—malignant glioma	3.2e-05	5.34e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PIK3CA—malignant glioma	3.2e-05	5.34e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PTEN—malignant glioma	3.13e-05	5.22e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PTGS1—malignant glioma	3.12e-05	5.21e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—AKT1—malignant glioma	3.08e-05	5.13e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—BCHE—malignant glioma	2.9e-05	4.84e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SLC5A5—malignant glioma	2.87e-05	4.78e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CAV1—malignant glioma	2.81e-05	4.68e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—AKT1—malignant glioma	2.62e-05	4.37e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—AKT1—malignant glioma	2.62e-05	4.37e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PIK3CA—malignant glioma	2.6e-05	4.34e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PIK3CG—malignant glioma	2.56e-05	4.27e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PPARG—malignant glioma	2.47e-05	4.12e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PIK3CA—malignant glioma	2.39e-05	3.98e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTP1—malignant glioma	2.31e-05	3.85e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PIK3CD—malignant glioma	2.25e-05	3.75e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CAT—malignant glioma	2.25e-05	3.75e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PIK3CA—malignant glioma	2.21e-05	3.68e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—AKT1—malignant glioma	2.13e-05	3.55e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NCOR1—malignant glioma	2.12e-05	3.54e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PIK3CB—malignant glioma	1.96e-05	3.27e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—AKT1—malignant glioma	1.95e-05	3.25e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PTGS2—malignant glioma	1.94e-05	3.24e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—AKT1—malignant glioma	1.8e-05	3.01e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CAV1—malignant glioma	1.73e-05	2.88e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PTEN—malignant glioma	1.69e-05	2.82e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.57e-05	2.63e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PPARG—malignant glioma	1.52e-05	2.54e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.38e-05	2.31e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.21e-05	2.01e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PTGS2—malignant glioma	1.2e-05	2e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PIK3CA—malignant glioma	1.19e-05	1.99e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PTEN—malignant glioma	1.04e-05	1.74e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—AKT1—malignant glioma	9.75e-06	1.63e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PIK3CA—malignant glioma	7.36e-06	1.23e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—AKT1—malignant glioma	6.01e-06	1e-05	CbGpPWpGaD
